2026 Hugh Auchincloss: Immunology Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Immunology	55	3781	3484	1734	1585	199	13848

Hugh Auchincloss publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Hugh Auchincloss sits on this spectrum.

62 publications 807+

This scientist: 199 publications — 34th percentile

34% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Hugh Auchincloss D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Hugh Auchincloss sits on this spectrum.

40 D-Index 157+

This scientist: 55 D-Index — 24th percentile

24% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

2020 - Distinguished Fellows of the American Association of Immunologists (AAI)

Overview

Hugh Auchincloss is affiliated with the National Institutes of Health in the United States. Their research primarily spans the field of medicine, with a focus on specialized subfields such as pulmonary and respiratory medicine, surgery, radiology, nuclear medicine and imaging, oncology, and biomedical engineering.

The scientist's work covers several key research topics including:

Lung Cancer Diagnosis and Treatment
Tracheal and airway disorders
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Esophageal Cancer Research and Treatment
Cardiac, Anesthesia and Surgical Outcomes
Airway Management and Intubation Techniques
Peripheral Nerve Disorders

Auchincloss has published extensively in notable scientific venues, with frequent contributions to:

Thoracic surgery clinics/Thorac. surg. clin.
American Journal of Respiratory and Critical Care Medicine
Annals of Surgery
The Annals of Thoracic Surgery
Annals of Thoracic Surgery Short Reports

Recent papers from their body of work include:

"Percutaneous Tracheostomy" (2020), published in New England Journal of Medicine
"Anatomy and Embryology of the Thoracic Outlet" (2020), published in Thoracic surgery clinics/Thorac. surg. clin.
"Polarization-Sensitive Endobronchial Optical Coherence Tomography for Microscopic Imaging of Fibrosis in Interstitial Lung Disease" (2022), published in American Journal of Respiratory and Critical Care Medicine
"Open, Video- and Robot-Assisted Thoracoscopic Lobectomy for Stage II-IIIA Non-Small Cell Lung Cancer" (2022), published in The Annals of Thoracic Surgery
"The COMPARE Study: Comparing Perioperative Outcomes of Oncologic Minimally Invasive Laparoscopic, da Vinci Robotic, and Open Procedures" (2024), published in Annals of Surgery

Frequent collaborators in their research activities include:

Michael Lanuti
Alexandra L. Potter
Chi-Fu Jeffrey Yang
Uma M. Sachdeva
Lana Schumacher

In recognition of their contributions to the field, Hugh Auchincloss was named a Distinguished Fellow of the American Association of Immunologists (AAI) in 2020.

Best Publications

International Trial of the Edmonton Protocol for Islet Transplantation

A. M James Shapiro;Camillo Ricordi;Bernhard J. Hering;Hugh Auchincloss

2452
Citations
The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice.

Mohammed Javeed I. Ansari;Alan D. Salama;Alan D. Salama;Tanuja Chitnis;Tanuja Chitnis;R. Neal Smith

1014
Citations
Xenogeneic transplantation. A review.

Hugh Auchincloss

533
Citations
Direct and indirect recognition: the role of MHC antigens in graft rejection

Dina S Gould;Hugh Auchincloss

511
Citations
A phase I trial of immunosuppression with anti-ICAM-1 (CD54) mAb in renal allograft recipients.

Craig Haug;Robert Colvin;Francis DELMONIco;Hugh Auchincloss

440
Citations
The role of "indirect" recognition in initiating rejection of skin grafts from major histocompatibility complex class II-deficient mice.

Hugh Auchincloss;Richard Lee;Susan Shea;Jay S. Markowitz

439
Citations
Mice lacking major histocompatibility complex class I and class II molecules.

M J Grusby;H Auchincloss;R Lee;R S Johnson

324
Citations
Indirect Recognition by Helper Cells Can Induce Donor-specific Cytotoxic T Lymphocytes In Vivo

R S Lee;M J Grusby;L H Glimcher;H J Winn

314
Citations
Symptomatic cytomegalovirus disease in the cytomegalovirus antibody seropositive renal transplant recipient treated with OKT3.

Patricia Hibberd;Nina Tolkoff-Rubin;A. Cosimi;Robert Schooley

307
Citations
Xenogeneic skin graft rejection is especially dependent on CD4+ T cells.

R N Pierson;H J Winn;P S Russell;H Auchincloss

286
Citations
Two levels of help for B cell alloantibody production.

D. J. R. Steele;T. M. Laufer;S. T. Smiley;Y. Ando

250
Citations
Effects of in vivo administration of anti-T3 monoclonal antibody on T cell function in mice. I. Immunosuppression of transplantation responses.

R Hirsch;M Eckhaus;H Auchincloss;D H Sachs

247
Citations
Analysis of the Role of Negative T Cell Costimulatory Pathways in CD4 and CD8 T Cell-Mediated Alloimmune Responses In Vivo

Toshiro Ito;Takuya Ueno;Michael R. Clarkson;Xueli Yuan

223
Citations
Skin graft rejection by beta 2-microglobulin-deficient mice.

M Zijlstra;H Auchincloss;J M Loring;C M Chase

200
Citations
Curative and β cell regenerative effects of α1-antitrypsin treatment in autoimmune diabetic NOD mice

Maria Koulmanda;Manoj Bhasin;Lauren Hoffman;Zhigang Fan

199
Citations
Xenogeneic proliferation and lymphokine production are dependent on CD4+ helper T cells and self antigen-presenting cells in the mouse.

R D Moses;R N Pierson;H J Winn;H Auchincloss

193
Citations
Antigen processing and presentation in transplantation

Hugh Auchincloss;Heena Sultan

193
Citations
Mechanisms of Transplantation Tolerance

B Charlton;H Auchincloss;C G Fathman

185
Citations
Liver transplantation for primary hepatic cancer

C E Haug;R L Jenkins;R J Rohrer;H Auchincloss

180
Citations
Acute humoral rejection in hepatitis C-infected renal transplant recipients receiving antiviral therapy.

Seema Baid;Nina Tolkoff-Rubin;Susan Saidman;Raymond Chung

173
Citations

Frequent Co-Authors

Mohamed H. Sayegh American University of Beirut

Francis L. Delmonico Harvard University

Nina Tolkoff-Rubin Harvard University

Cosimi Ab Harvard University

David H. Sachs Columbia University

Paul S. Russell Harvard University

Alan D. Salama University College London

Michael J. Grusby Harvard University

Nader Najafian Brigham and Women's Hospital

Laurie H. Glimcher Harvard University

External Links

Wikipedia of Hugh Auchincloss Personal website of Hugh Auchincloss

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

For those interested in immunology, pursuing related online degrees can open numerous career pathways in healthcare and research. Nurses play a crucial role in immunology settings, making programs like online adn programs for non nurses an accessible entry point for many. These programs help individuals without a nursing background transition smoothly into the field.

If you’re looking for quicker routes, some absn programs with high acceptance rates provide accelerated nursing education, enabling faster entry into immunology-related careers. Similarly, starting with an LPN license from one of the many easy admission lpn programs can be a practical stepping stone into patient care roles concerning immunological health.

For advanced practice, becoming a nurse practitioner is a promising option. Exploring nurse practitioner programs with easy admission allows prospective students to find accessible routes to elevated responsibilities in immunology treatment and research.

Overall, combining immunology knowledge with nursing credentials expands career opportunities, from clinical roles to research and education. Online programs with flexible admissions make these pathways more achievable than ever.